GLP-1 and Hair Loss: Is There a Connection?

Short answer: hair shedding has been reported by some people on GLP-1 medications, but current evidence points to rapid, significant weight loss itself as the likely driver, rather than the medication directly damaging hair. This pattern, called telogen effluvium, is a known response to any large, fast weight change or nutritional shift, not something unique to GLP-1s.

What telogen effluvium is

Telogen effluvium is temporary, diffuse hair shedding triggered by a physical stressor to the body, rapid weight loss, illness, surgery, or significant calorie or nutrient restriction are common triggers. It typically shows up a few months after the triggering event and is usually reversible once the underlying stressor resolves.

Why GLP-1 users report it

Because GLP-1 medications can produce significant weight loss relatively quickly, and often reduce appetite enough to affect overall nutrient intake, users are in a group where the known triggers for telogen effluvium, rapid weight change and potential nutritional gaps, are more common. This doesn't appear in the primary efficacy data from trials like STEP 1 and SURMOUNT-1 the way gastrointestinal side effects do, but it has been reported anecdotally and in post-marketing observation.

What may help

Adequate protein intake, overall nutritional adequacy while losing weight, and avoiding excessively rapid loss are commonly recommended. If you notice significant shedding, it's worth discussing with your provider, both to confirm the likely cause and to review whether your nutrition needs adjustment during treatment.